Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 17,885 | 15,313 | 10,161 | 11,611 | 8,113 |
| Cost of Goods | 10,350 | 9,988 | 7,028 | 9,335 | 5,641 |
| Gross Profit | 7,535 | 5,326 | 3,133 | 2,275 | 2,472 |
| Operating Expenses | 9,951 | 11,545 | 7,547 | 14,247 | 10,977 |
| Operating Income | -2,066 | -5,231 | -4,386 | -11,636 | -7,864 |
| Interest Expense | 567 | 113 | -11 | 29 | 32 |
| Other Income | 0 | -44 | -44 | 3 | 1 |
| Pre-tax Income | -2,633 | -5,388 | -4,420 | -11,662 | -7,895 |
| Income Tax | 5 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -2,638 | -5,388 | -4,420 | -11,662 | -7,895 |
| Net Income Discontinuous | -134 | N/A | N/A | N/A | N/A |
| Net Income | $-2,771 | $-5,388 | $-4,420 | $-11,662 | $-7,895 |
| EPS Basic Total Ops | -0.08 | -0.15 | -0.12 | -0.39 | -0.36 |
| EPS Basic Continuous Ops | -0.07 | -0.15 | -0.13 | -0.39 | -0.35 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.08 | -0.15 | -0.12 | -0.39 | -0.36 |
| EPS Diluted Continuous Ops | -0.07 | -0.15 | -0.13 | -0.39 | -0.35 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,736 | $-5,019 | $-4,162 | $-11,292 | $-7,465 |